Article Figures & Data
Figures
- Figure 1.
Relapses in 69 patients with newly diagnosed giant cell arteritis.
Tables
- Table 1.
Symptoms of active giant cell arteritis during all 59 relapses, and by prednisone dose at time of relapse. Values expressed as no. relapses with the symptom recorded divided by total no. relapses at that dose of prednisone (%). Steroid data were unavailable in 2 relapses.
Symptoms All, n = 59 Prednisone, 0 mg, n =11 Prednisone, 1–10 mg, n = 32 Prednisone, 11–20 mg, n = 11 Prednisone, > 20 mg, n = 3 Cranial Headache 25 (42) 1 (9) 12 (38) 8 (73) 3 (100) Scalp tenderness 19 (32) 0 (0) 7 (22) 9 (82) 2 (67) New temporal artery pain 6 (10) 0 (0) 2 (6) 2 (18) 2 (67) Carotidynia 2 (3) 0 (0) 2 (6) 0 (0) 0 (0) Jaw/tongue claudication 8 (14) 1 (9) 4 (13) 3 (27) 0 (0) Visual manifestations 3 (5) 0 (0) 3 (9) 0 (0) 0 (0) PMR/arthralgia 30 (51) 8 (73) 16 (50) 5 (45) 1 (33) Upper extremity claudication 6 (10) 2 (18) 3 (9) 0 (0) 0 (0) Lower extremity claudication 1 (2) 0 (0) 1 (3) 0 (0) 0 (0) Constitutional (weight loss, fatigue) 8 (14) 2 (18) 4 (13) 1 (9) 1 (33) PMR: polymyalgia rheumatica.
In this issue
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study
